Nature Communications (Jul 2024)

Gene body DNA hydroxymethylation restricts the magnitude of transcriptional changes during aging

  • James R. Occean,
  • Na Yang,
  • Yan Sun,
  • Marshall S. Dawkins,
  • Rachel Munk,
  • Cedric Belair,
  • Showkat Dar,
  • Carlos Anerillas,
  • Lin Wang,
  • Changyou Shi,
  • Christopher Dunn,
  • Michel Bernier,
  • Nathan L. Price,
  • Julie S. Kim,
  • Chang-Yi Cui,
  • Jinshui Fan,
  • Moitrayee Bhattacharyya,
  • Supriyo De,
  • Manolis Maragkakis,
  • Rafael de Cabo,
  • Simone Sidoli,
  • Payel Sen

DOI
https://doi.org/10.1038/s41467-024-50725-y
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 22

Abstract

Read online

Abstract DNA hydroxymethylation (5hmC), the most abundant oxidative derivative of DNA methylation, is typically enriched at enhancers and gene bodies of transcriptionally active and tissue-specific genes. Although aberrant genomic 5hmC has been implicated in age-related diseases, its functional role in aging remains unknown. Here, using mouse liver and cerebellum as model organs, we show that 5hmC accumulates in gene bodies associated with tissue-specific function and restricts the magnitude of gene expression changes with age. Mechanistically, 5hmC decreases the binding of splicing associated factors and correlates with age-related alternative splicing events. We found that various age-related contexts, such as prolonged quiescence and senescence, drive the accumulation of 5hmC with age. We provide evidence that this age-related transcriptionally restrictive function is conserved in mouse and human tissues. Our findings reveal that 5hmC regulates tissue-specific function and may play a role in longevity.